BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202 USD | +4.56% |
|
+5.12% | -21.94% |
| Apr. 24 | Health Care Down Amid Mixed Earnings -- Health Care Roundup | DJ |
| Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Presentation Operator MessageOperator (Operator)Good morning. My name is Cecilia, and I will b...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
202
USD
Average target price
288.4
USD
Spread / Average Target
+42.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.94% | 29.36B | |
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| +53.11% | 24.49B | |
| -5.41% | 17.31B | |
| -44.23% | 11.26B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| -0.22% | 8.31B | |
| +2.09% | 7.63B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc., Q1 2022 Earnings Call, May 03, 2022
